Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study.

Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Oner SY, Yildiz F, Yilmaz S, Bakirli DE, Tufan MA, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Cetin GY, Erten S, Gonullu E, Temel T, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kisacik B, Sayarlioglu M, Korkmaz C.

Rheumatology (Oxford). 2014 Apr;53(4):741-5. doi: 10.1093/rheumatology/ket400. Epub 2013 Dec 24.

PMID:
24369413
2.

Genotype-phenotype correlation in patients with familial Mediterranean fever in East Anatolia (Turkey).

Albayrak F, Selcuk NY, Odabas AR, Cetinkaya R, Pirim I.

Genet Test Mol Biomarkers. 2010 Jun;14(3):325-8. doi: 10.1089/gtmb.2009.0189.

PMID:
20373849
3.

Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients.

Akpolat T, Özkaya O, Özen S.

Gene. 2012 Jan 15;492(1):285-9. doi: 10.1016/j.gene.2011.10.012. Epub 2011 Oct 13. Review.

PMID:
22037353
4.

Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.

Abedi AS, Nakhjavani JM, Etemadi J.

Transplant Proc. 2013;45(10):3502-4. doi: 10.1016/j.transproceed.2013.09.021.

PMID:
24314942
5.

Predictors of AA amyloidosis in familial Mediterranean fever.

Mukhin NA, Kozlovskaya LV, Bogdanova MV, Rameev VV, Moiseev SV, Simonyan AKh.

Rheumatol Int. 2015 Jul;35(7):1257-61. doi: 10.1007/s00296-014-3205-x. Epub 2015 Jan 14.

PMID:
25586652
6.

The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.

Turkcapar N, Tuncali T, Kutlay S, Burhan BY, Kinikli G, Erturk S, Duman M.

Rheumatol Int. 2007 Apr;27(6):545-51. Epub 2006 Nov 11.

PMID:
17102945
7.

Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk.

Ebrahimi-Fakhari D, Schönland SO, Hegenbart U, Lohse P, Beimler J, Wahlster L, Ho AD, Lorenz HM, Blank N.

Scand J Rheumatol. 2013;42(1):52-8. doi: 10.3109/03009742.2012.714796. Epub 2012 Nov 8.

PMID:
23137073
8.

Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features.

Pasa S, Altintas A, Devecioglu B, Cil T, Danis R, Isi H, Bayan K, Tuzun Y, Ecer S, Batun S, Ayyildiz O.

Amyloid. 2008 Mar;15(1):49-53. doi: 10.1080/13506120701815456.

PMID:
18266121
9.

MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis.

Olgun A, Akman S, Kurt I, Tuzun A, Kutluay T.

Rheumatol Int. 2005 May;25(4):255-9. Epub 2004 Jan 15.

PMID:
14727057
10.

Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population.

Duşunsel R, Dursun I, Gündüz Z, Poyrazoğlu MH, Gürgöze MK, Dundar M.

Pediatr Int. 2008 Apr;50(2):208-12. doi: 10.1111/j.1442-200X.2008.02554.x.

PMID:
18353061
11.

Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever.

Ben-Zvi I, Danilesko I, Yahalom G, Kukuy O, Rahamimov R, Livneh A, Kivity S.

Isr Med Assoc J. 2012 Apr;14(4):221-4.

12.

Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E; Turkish FMF Study Group.

Medicine (Baltimore). 2005 Jan;84(1):1-11.

13.

[Familial Mediterranean Fever (FMF): from diagnosis to treatment].

Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A.

Sante. 2004 Oct-Dec;14(4):261-6. Review. French.

14.

Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis.

Atagunduz MP, Tuglular S, Kantarci G, Akoglu E, Direskeneli H.

Nephron Clin Pract. 2004;96(4):c131-5.

PMID:
15122067
15.

A molecular analysis of familial Mediterranean fever disease in a cohort of Turkish patients.

Dundar M, Kiraz A, Emirogullari EF, Saatci CE, Taheri S, Baskol M, Polat S, Ozkul Y.

Ann Saudi Med. 2012 Jul-Aug;32(4):343-8.

17.

Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever.

Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Geneviève D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S.

Am J Hum Genet. 2000 Nov;67(5):1136-43. Epub 2000 Oct 3.

18.

The M694I/M694I genotype: A genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever.

Ait-Idir D, Djerdjouri B, Bouldjennet F, Taha RZ, El-Shanti H, Sari-Hamidou R, Khellaf G, Benmansour M, Benabadji M, Haddoum F.

Eur J Med Genet. 2017 Mar;60(3):149-153. doi: 10.1016/j.ejmg.2016.12.003. Epub 2016 Dec 10.

PMID:
27956278
20.

Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia.

Ureten K, Gönülalan G, Akbal E, Güneş F, Akyürek O, Ozbek M, Oztürk MA.

Rheumatol Int. 2010 May;30(7):911-5. doi: 10.1007/s00296-009-1073-6. Epub 2009 Jul 30.

PMID:
19641922

Supplemental Content

Support Center